From: Proceedings of the 24th Paediatric Rheumatology European Society Congress: Part one
Patient | JIA subtype | Gender; Ethnicity | Age of uveitis diagnosis (years) | Uveitis diagnosis from JIA diagnosis (years) | Symptom onset to diagnosis (months) | Symptoms | Disease extent | Complication | Treatment |
---|---|---|---|---|---|---|---|---|---|
1 | ERA | Male; Indonesian | 9.2 | – 3.8 | 0.6 | Pain and redness | Bilateral; anterior | – | Topical steroids, Adalimumab |
2 | ERA | Male; Indonesian | 13.8 | 1.3 | 1.1 | Redness, blurring of vision, photophobia | Bilateral; anterior | Macular oedema | Topical and systemic steroids, MTX, Adalimumab |
3 | ERA | Male; Indian | 13.0 | 0 | 1.6 | Redness | Bilateral; anterior | – | Topical and systemic steroids, MTX, Adalimumab |
4 | Oligoarticular-extended | Male; Indian | 5.1 | 1.5 | 5.2 | Left eye ptosis | Left; panuveitis | Macular oedema, glaucoma, cataract | Topical and systemic steroids, MTX, Infliximab; cataract surgery; YAG laser |